Exercise-induced factor (e.g., irisin, SPARC, oncostatin M), released from contracting skeletal muscles, can exert anti-tumor effects by inhibiting cancer cell proliferation, inducing apoptosis, and reducing angiogenesis within the tumor microenvironment [15]. Here, FNDC5 is linked to neoplasm.